Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ludwig EnterprisesLUDG EBIT per Share is $-0.01 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 684 Medical Devices & Instruments companies, Ludwig Enterprises ranks worse than 99.12% on this metric.
Ludwig Enterprises's EBIT per Share for the
three
months ended in Mar. 2026 was $0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was -76.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Ludwig Enterprises's EBIT per Share or its related term are showing as below:
LUDG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -76.5 Med: -76.5 Max: -76.5
Current: -76.5
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Ludwig Enterprises was -76.50% per year. The lowest was -76.50% per year. And the median was -76.50% per year.
LUDG's 3-Year EBIT Growth Rate is ranked worse than 99.12% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs LUDG: -76.50
Ludwig Enterprises (OTCPK:LUDG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Ludwig Enterprises EBIT per Share Related Terms
Ludwig Enterprises EBIT per Share Historical Data
* Premium members only.
The historical data trend for Ludwig Enterprises's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises (LUDG) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ludwig Enterprises and its competitors. According to the industry distribution chart, Ludwig Enterprises ranks #678 out of 684 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Ludwig Enterprises' EBIT per Share too high?
Ludwig Enterprises' current EBIT per Share is $-0.01. Based on the distribution chart, Ludwig Enterprises ranks #678 out of 684 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Ludwig Enterprises' EBIT per Share compare to TNON and POAS?
According to the Medical Devices & Instruments industry distribution chart, Ludwig Enterprises ranks #678 out of 684 companies for EBIT per Share. This places Ludwig Enterprises in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ludwig Enterprises and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ludwig Enterprises's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ludwig Enterprises stock overvalued right now?
Ludwig Enterprises (LUDG) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Ludwig Enterprises (LUDG), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ludwig Enterprises Inc is an early-stage genomic technology company focused on developing screening tests for inflammation-related chronic diseases, including cancers. Its platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits designed to provide a differentiated and patient-friendly approach to cancer screening. The company's business model combines a business-to-business-to-consumer (B2B2C) approach with partnerships through CLIA-certified laboratories. It is focused on offering home collection kits directly to patients, supported by certified genetic counselors, while also enabling independent laboratories to provide the Revealia Breast test (Ludwig's key product candidate) as a Laboratory Developed Test (LDT).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUDG has been successfully added to your 
